Consumption of black and green tea has no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals

European Journal of Clinical Nutrition

Volumn 54, Issue 10, 2000, Pages 757-763

  De Maat, M P M ^a   Pijl, H ^b   Kluft, C ^a   Princen, H M G ^a  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8A; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MINERAL WATER; PLASMA PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYPHENOL; PROUROKINASE; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; FOOD INTAKE; HEALTH STATUS; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; NORMAL HUMAN; PROTEIN BLOOD LEVEL; RISK FACTOR; SMOKING; TEA; VASCULAR ENDOTHELIUM;

ACUTE-PHASE REACTION; ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOGEN; FLAVONOIDS; HEMOSTASIS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NETHERLANDS; PHENOLS; POLYMERS; RISK FACTORS; SMOKING; TEA;

EID: 0033754768     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1601084     Document Type: Article

References (51)

1. Anti-inflammatory diet in rheumatic diseases
2. Manufacturing and chemistry of tea
3. Interaction among hepatocyte-stimulating factors, interleukin-1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells
4. Atherosclerosis: Basic mechanisms. Oxidation, inflammation and genetics
5. Quantitation of urokinase antigen in plasma and culture media by use of an ELISA
6. Lower levels of vitamin C and carotenes in plasma of cigarette smokers
7. The free radical chemistry of cigarette smoke and its toxicological implications
8. Measurement of plasminogen activator inhibitor-1 in biological fluids with a murine monoclonal antibody-based enzyme-linked immunosorbant assay
9. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers
10. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA study
11. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature
12. Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females
13. Effects of fish oil on some parameters of fibrinolysis and lipoprotein (a) in healthy subjects
14. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
15. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European concerted action on thrombosis and disabilities angina pectoris study group
16. Interleukin-6 and the acute phase response
17. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly study
18. Antioxidant flavonols and coronary heart disease risk
19. Flavonoid intake and the longterm risk of coronary heart disease and cancer in the seven countries study
20. Alpha-tocopherol, a potent modulator of endothelial cell function
21. Why drinking green tea could prevent cancer
22. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: Results from an in vitro and a dietary supplement study
23. Von Willebrand in plasma: A novel risk factor for recurrent myocardial infarction and death
24. The antioxidant vitamins and cardiovascular disease: A critical review of epidemiologic and clinical trial data
25. Protection against 12-O-tetradecanoylphorbol-13-acetate-caused inflammation in SENCAR mouse ear skin by polyphenolic fraction isolated from green tea
26. Flavonoid intake and coronary mortality in Finland: A cohort study
27. Analysis of plasma and urinary tea polyphenols in human subjects
28. Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factos: A pilot study
29. PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: Relation to environmental and genetic determinants
30. Haemostatic function and ischaemic heart disease: Principal results of the Northwick park heart study
31. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: An International study
32. Activation of the coagulant pathway in cigarette smokers
33. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
34. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage
35. A depression of the urokinase-related fibrinolytic system in plasma in patients with acute myocardial infarction compared to unstable angina pectoris
36. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma
37. Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking
38. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers
39. Structure-antioxidant activity relationships of flavonoids and phenolic acids
40. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
41. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals
42. Atherosclerosis - An inflammatory disease
43. Tea consumption. Relationship to cholesterol, blood pressure, and coronary mortality
44. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European concerted action on thrombosis and disabilities angina pectoris study group
45. Bioavailability of catechins from tea: The effect of milk
46. Gerinnugsphysiologische schnellmethode zur bestimmung des fibrinogens
47. Tea drinking and haemostasis: A randomized, placebo-controlled, crossover study in free-living subjects
48. Antioxidant properties of ethanolic and aqueous extracts of green tea compared to black tea
49. Antioxidant properties of fractions of polyphenol constituents from green, oolong and black teas
50. Blood and urine levels of tea catechins after ingestion of different amount of green tea by human volunteers
51. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model